12/18
09:19 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
12/18
08:55 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
12/10
10:00 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
12/10
10:00 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
12/9
10:39 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
12/9
10:39 am
agio
Rating for AGIO
Medium
Report
Rating for AGIO
11/1
12:38 pm
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $55.00 price target on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $55.00 price target on the stock.
11/1
12:38 pm
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $55.00 price target on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $55.00 price target on the stock.
11/1
12:31 pm
agio
Rating for AGIO
Low
Report
Rating for AGIO
11/1
12:31 pm
agio
Rating for AGIO
Low
Report
Rating for AGIO
11/1
10:18 am
agio
Rating for AGIO
Low
Report
Rating for AGIO
11/1
10:18 am
agio
Rating for AGIO
Low
Report
Rating for AGIO